Search results for "BES"

showing 10 items of 3692 documents

Psychometric Evaluation of the Eating Disorder Examination Adapted for Children

2013

The Eating Disorder Examination adapted for children (ChEDE) is the child version of the semi-structured gold standard eating disorder interview for adults. This study was a comprehensive test statistic evaluation of the German ChEDE in a large sample of children and adolescents with anorexia nervosa, binge eating disorder, loss of control eating, overweight and obesity, as well as non-eating-disordered and chronically ill control probands (n = 352). Excellent inter-rater reliability, adequate internal consistency and satisfactory stability of ChEDE indicators were demonstrated. ChEDE indicators discriminated between diverse forms of eating and weight disturbances and normative eating and w…

medicine.medical_specialtyPsychometricsdigestive oral and skin physiologyOverweightmedicine.diseaseAnorexia nervosaObesityPsychiatry and Mental healthClinical PsychologyEating disordersBinge-eating disordermedicineNormativemedicine.symptomPsychiatryPsychologyPsychopathologyClinical psychologyEuropean Eating Disorders Review
researchProduct

Unfavorable influence of structured exercise program on total leisure-time physical activity

2012

In randomized controlled trials (RCTs), with customized structured physical exercise activity (SPEA) interventions, the dose of leisure-time physical activity (LTPA) should exceed the LTPA dose of the nonexercising control (C) group. This increase is required to substantiate health improvements achievable by exercise. We aimed to compare the dose of SPEA, LTPA, and total LTPA (SPEA + LTPA) between a randomized Nordic walking (NW) group, a power-type resistance training (RT) group, and a C group during a 12-week exercise intervention in obese middle-aged men (n = 144) with impaired glucose regulation. The dose of physical activity was measured with diaries using metabolic equivalents. No sig…

medicine.medical_specialtyRct designPhysical activityPhysical Therapy Sports Therapy and RehabilitationPhysical exercise030204 cardiovascular system & hematologyMetabolic equivalentlaw.invention03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationRandomized controlled trialWeight losslawmedicineOrthopedics and Sports Medicine030212 general & internal medicinebusiness.industryResistance trainingmedicine.diseaseObesity3. Good healthPhysical therapymedicine.symptombusinesshuman activitiesScandinavian Journal of Medicine & Science in Sports
researchProduct

Could inherited predisposition drive fatty liver disease in non-obese Germans? Results from eight tertiary referral centers

2018

medicine.medical_specialtyReferralNon obesebusiness.industryInternal medicineFatty liverGastroenterologyMedicineDiseasebusinessmedicine.diseaseInherited PredispositionZeitschrift für Gastroenterologie
researchProduct

The effectiveness of secondary and tertiary care lifestyle intervention in morbidly obese patients: a 1-year non-randomized controlled pragmatic clin…

2013

Summary In this non-randomized clinical pragmatic trial, we aimed to compare the effectiveness of an outpatient intensive lifestyle intervention (ILI) programme conducted in a tertiary care obesity rehabilitation centre with an outpatient moderate lifestyle intervention (MLI) programme at a secondary care obesity centre. Effectiveness was measured in terms of the 1-year effect each programme had on body weight, physical activity and health-related quality of life (HRQL). A total of 232 morbidly obese subjects were recruited to the ILI group and 140 to the MLI group, with retention rates of 78% and 44%, respectively. The ILI group had a significantly larger mean (95% confidence interval [CI]…

medicine.medical_specialtyRehabilitationbusiness.industryEndocrinology Diabetes and Metabolismmedicine.medical_treatmentmedicine.diseaseTertiary careObesityConfidence intervalClinical trialQuality of lifeWeight lossLifestyle interventionmedicinePhysical therapymedicine.symptombusinessClinical Obesity
researchProduct

Soluble ligands and their receptors in human embryo development and implantation.

2014

Extensive evidence suggests that soluble ligands and their receptors mediate human preimplantation embryo development and implantation. Progress in this complex area has been ongoing since the 1980s, with an ever-increasing list of candidates. This article specifically reviews evidence of soluble ligands and their receptors in the human preimplantation stage embryo and female reproductive tract. The focus will be on candidates produced by the human preimplantation embryo and those eliciting developmental responses in vitro, as well as endometrial factors related to implantation and receptivity. Pathways to clinical translation, including innovative diagnostics and other technologies, are al…

medicine.medical_specialtyReproductive Techniques AssistedEndocrinology Diabetes and Metabolismmedicine.medical_treatmentReproductive medicineEmbryonic DevelopmentReceptors Cell SurfaceBiologyEndometriumBioinformaticsLigandsHuman chorionic gonadotropinEmbryo Culture TechniquesEndometriumEndocrinologyPregnancymedicineHumansReceptors Growth FactorBlastocystEmbryo ImplantationReceptors CytokineReceptorGrowth SubstancesFallopian TubesIn vitro fertilisationEmbryoCoculture TechniquesHormonesCulture MediaMicroRNAsmedicine.anatomical_structureBlastocystImmunologyCytokinesFemaleEmbryo qualityEndocrine reviews
researchProduct

Relaxant effect of dopamine on the isolated rat uterus.

1988

The effect of dopamine was studied on the isolated uterus of diethylstilboestrol-treated rats. Dopamine, at concentrations (10(7)-10(-4) M) produced a concentration-dependent relaxation in the K+-depolarized rat uterus. On a molar basis, dopamine was about 500 times less potent than adrenaline in relaxing the uterus, the maximum degree of relaxation obtained with both drugs was the same. Pretreatment of the rats with reserpine (5 mg/kg) did not produce any modification of the dose-response curve to dopamine. Similarly, cocaine (3 x 10(-6) M) failed to modify the relaxant effect of dopamine. The dopamine induced relaxation was inhibited by propranolol (10(-9)-10(-7) M) in a dose-dependent ma…

medicine.medical_specialtyReserpineEpinephrineDopamineBiologyIn Vitro Techniqueschemistry.chemical_compoundUterine ContractionDopamineInternal medicinemedicinePrazosinAnimalsNeurotransmitterDiethylstilbestrolPharmacologyDose-Response Relationship DrugUterusRats Inbred StrainsGeneral MedicinePrazosinReserpineBenzazepinesPropranololRatsEndocrinologyEpinephrinechemistryDopamine receptorCatecholamineFemaleSulpirideSulpiridemedicine.drugNaunyn-Schmiedeberg's archives of pharmacology
researchProduct

Fructose and cardiometabolic disorders: the controversy will, and must, continue

2010

The present review updates the current knowledge on the question of whether high fructose consumption is harmful or not and details new findings which further pushes this old debate. Due to large differences in its metabolic handling when compared to glucose, fructose was indeed suggested to be beneficial for the diet of diabetic patients. However its growing industrial use as a sweetener, especially in soft drinks, has focused attention on its potential harmfulness, possibly leading to dyslipidemia, obesity, insulin resistance/metabolic syndrome and even diabetes. Many new data have been generated over the last years, confirming the lipogenic effect of fructose as well as risks of vascular…

medicine.medical_specialtyReviewFructoseBiologyBioinformaticschemistry.chemical_compoundInsulin resistanceRisk FactorsInternal medicineDiabetes mellitusmedicineHumansVascular DiseasesTriglyceridesHypertriglyceridemialcsh:R5-920HypertriglyceridemiaFructoseGeneral Medicinemedicine.diseaseObesityMetabolic syndromeDietEndocrinologychemistryLiverSweetening AgentsHypertensionUric acidMetabolic syndromelcsh:Medicine (General)Uric acidDyslipidemiaClinics
researchProduct

Obesity and cardiovascular risk: the new public health problem of worldwide proportions

2004

Obesity could be considered a new global health epidemic above all others, especially when it is characterized by central fat distribution. This is illustrated by dramatic provisional data, indicating a continuous increase in the trend of overweight and obese individuals in several countries, including the USA and countries in Europe. Several epidemiological, pathophysiological and clinical studies clearly indicate that two of the major independent risk factors for cardiovascular disease or events are being overweight, and obesity. Accordingly, weight loss and prevention of weight gain has to be considered one of the most important strategies to reduce the incidence of cardiovascular diseas…

medicine.medical_specialtySettore MED/09 - Medicina InternaCoronary DiseaseHyperlipidemiasDiseaseOverweightGlobal HealthBody Mass IndexRisk FactorsWeight lossEnvironmental healthEpidemiologyInternal MedicinemedicineGlobal healthHumansObesityHeart Failurecardiovascular risk heart failure hypertension ischemic heart disease obesitybusiness.industryPublic healthGeneral Medicinemedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareObesityUnited StatesEuropeCardiovascular DiseasesHypertensionPhysical therapyAnti-Obesity Agentsmedicine.symptomCardiology and Cardiovascular MedicinebusinessBody mass indexExpert Review of Cardiovascular Therapy
researchProduct

A novel component of the metabolic syndrome: The oxidative stress

2009

The metabolic syndrome (MS) represents a cluster of cardiovascular (CV) risk factors associated to CV disease and type 2 diabetes. It is still under debate whether MS is a mere aggregation of risk factors or it represents a clinical entity with visceral obesity as underlying pathophysiological trigger. The publication of several diagnostic criteria of MS by scientific associations or experts panels reflects this uncertainty in understanding the real nature of MS. Besides the metabolic disturbances of MS, as visceral obesity, hypertriglyceridemia, low HDL cholesterol, hypertension and hyperglycemia, novel mechanisms of arterial damage have been identified. This paper reviews the evidence sho…

medicine.medical_specialtySettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismMedicine (miscellaneous)Blood lipidsType 2 diabetesDiseaseBiologyBioinformaticsmedicine.disease_causeRisk FactorsInternal medicineDiabetes mellitusmedicineAnimalsHumansDyslipidemiasInflammationMetabolic SyndromeNutrition and DieteticsHypertriglyceridemiaCardiovascular riskmedicine.diseaseObesityOxidative StressEndocrinologyDiabetes Mellitus Type 2Cardiovascular DiseasesObesity AbdominalHypertensionMetabolic syndromeCardiology and Cardiovascular MedicineOxidative stressNutrition, Metabolism and Cardiovascular Diseases
researchProduct

Social disparities, health risk behaviors, and cancer

2013

Background: Overall cancer incidence rates decreased in the most recent time period in both men and women, largely due to improvements in surgical therapeutic approaches (tertiary prevention) and screening programs (secondary prevention), but differences in cancer incidence and survival according to socioeconomic status are documented worldwide. Health risk behaviors, defined as habits or practices that increase an individual’s likelihood of harmful health outcomes, are thought to mediate such inequalities. Discussion: Obesity has been related with increased cancer incidence and mortality due to imbalance of leptin and adiponectin which are connected to activation of PI3K, MAPK, and STAT3 p…

medicine.medical_specialtySettore MED/09 - Medicina InternaInequalitySettore MED/06 - Oncologia Medicamedia_common.quotation_subjectMEDLINERisk-TakingRisk FactorsNeoplasmsmedicineHumansObesityHealth riskSettore MED/49 - Scienze Tecniche Dietetiche ApplicateSocioeconomic statusmedia_commonDiet cancer risk behaviorbusiness.industryIncidence (epidemiology)IncidenceSOCIAL DISPARITIESCancerGeneral Medicinemedicine.diseaseObesityCANCERSurgerySocioeconomic FactorsCANCER; SOCIAL DISPARITIESSurgerybusinessTertiary PreventionResearch Article
researchProduct